▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Plus

Neg

Email

EARNINGS SUMMARY: Details of AGNC Investment Corp. Q3 Earnings Report

By RTTNews Staff Writer ✉ | Published: 10/30/2019 4:07 PM ET

Below are the earnings highlights for AGNC Investment Corp. (AGNC):

-Earnings: -$17 million in Q3 vs. $207 million in the same period last year.
-EPS: -$0.03 in Q3 vs. $0.45 in the same period last year.

For comments and feedback contact: editorial@rttnews.com

New Drugs Approved In December

New Drugs Approved In December

PDUFA Biotech stocks Chemotherapy COVID19 vaccines heart failure lupus ARS

Biotech Stocks Facing FDA Decision In January 2021

New Drugs Approved In November

New Drugs Approved In November

Latest Updates on COVID-19

AstraZeneca COVID-19 Vaccine Batch Suspended In Austria

EU, Italy Block AstraZeneca COVID-19 Vaccine Shipment To Australia

US Records Encouraging Figures In Key COVID Metrics

New US COVID Cases At Its Lowest Level In Nearly 5 Months

FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine

Read More

COVID-19: Drugs in Development

RELATED NEWS

AGNC Investment Q4 20 Earnings Conference Call At 8:30 AM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

FDA Grants EUA For T-Detect Covid Test To Detect Past COVID-19 Infection

AstraZeneca COVID-19 Vaccine Batch Suspended In Austria

DuPont To Buy Laird Performance Materials From Advent International For $2.3 Bln - Quick Facts

Hu Chocolate Covered Hunks-Sour Goldenberries Recalled

Polaris Recalls Ranger Off-Road Vehicles, PRO XD Utility Vehicles

EU, Italy Block AstraZeneca COVID-19 Vaccine Shipment To Australia

Chipotle In Deal With E.l.f. For Vegan, Cruelty-free Makeup Collection

UK CMA Probes Apple Over Suspected Anti-competitive Behavior - Quick Facts

Kroger Q4 Adj. EPS Tops Estimates, But Revenue Miss

Retail Sales Poised For Growth In 2021, But How Much?

Merck KGaA FY20 Profit Up, Lifts Dividend; Sees Organic Growth In FY21

Disney To Close At Least 60 North American Stores, To Focus Online

KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent

Merck KGaA FY20 Profit Up, Lifts Dividend; Sees Organic Growth In FY21

EU, Italy Block AstraZeneca COVID-19 Vaccine Shipment To Australia

EU Opens Formal Probe Against Teva For Anticompetitive Conduct - Quick Facts

Roche: FDA Approves Actemra/RoActemra For Systemic Sclerosis-associated Interstitial Lung Disease

Amgen To Acquire Five Prime Therapeutics - Quick Facts

Spirent Acquires OctoScope

Sanofi : FDA Accepts Dupixent For Review In Children With Moderate-to-severe Asthma

Luminex Gets Emergency Use Authorization For Expanded Version Of NxTAG Respiratory Pathogen Panel

CureVac, Novartis Sign Initial Agreement For Manufacturing Of CureVac's COVID-19 Vaccine Candidate

Merck KGaA FY20 Profit Climbs, Lifts Dividend; Sees Organic Growth In FY21

Novartis Chief Legal Officer Shannon Klinger To Step Down, Names Thomas Kendris CLO Ad Interim

KPS Capital Partners To Buy Global Aluminum Rolling Business From Norsk Hydro For About $1.67 Bln

Kroger Q4 Adj. EPS Tops Estimates, But Revenue Miss

Amgen To Acquire Five Prime Therapeutics - Quick Facts

Merck KGaA FY20 Profit Up, Lifts Dividend; Sees Organic Growth In FY21

CRH Plc FY20 Profit Down, Lifts Dividend; Says Near-term Outlook Uncertain

Entain Plc FY Underlying Operating Profit Slightly Rises

Hunting Plc Slips To Loss In FY20 On Weak Revenues

Aviva Announces Sale Of Remaining Italian Life And General Insurance Businesses For €873 Mln In Cash

Sage Group Begins Share Buyback Programme Of Up To £300 Mln- Quick Facts

Knorr-Bremse FY20 Profit Down, Order Book Up; Sees Higher Sales In FY21 - Quick Facts

Evonik Q4 Profit Drops - Quick Facts

Sanofi : FDA Accepts Dupixent For Review In Children With Moderate-to-severe Asthma